The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Delivery > OraPharma, Inc.

OraPharma, Inc.
Nasdaq: OPHM
Change
symbol:
     
 PROFILE
OraPharma wants to save your toothy grin. The development-stage company's ARESTIN is aimed at wiping out periodontitis, a leading cause of adult tooth loss. Using a polymer microsphere delivery system licensed from American Home Products subsidiary American Cyanamid, ARESTIN delivers a sustained dose of antibiotic to an infection site after plaque removal. The company is also developing a treatment for oral mucositis (a condition that occurs frequently in patients receiving chemotherapy or radiation therapy) and a therapy for bone and soft-tissue regeneration.

 COMPETITION
Atrix Laboratories, Inc. (ATRX)
CollaGenex Pharmaceuticals, Inc. (CGPI)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: 0.0%
Employees: 18
Revenue per employee: $5,555.56

 KEY PEOPLE
• Michael D. Kishbauch
    CEO
• James A. Ratigan
    CFO

 CONTACT INFO
732 Louis Dr.
Warminster, PA 18974
US
Phone: 215-956-2200
Fax: 215-443-9531
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001